BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16395832)

  • 1. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Almyroudis NG; Segal BH
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395832
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Pasqualotto AC; Rosa DD; Machado AL
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Ito JI; Tegtmeier BR; O'Donnell MR
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395829
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Castagna L; Santoro A
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395831
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic antimicrobial agents and the importance of fitness.
    Baden LR
    N Engl J Med; 2005 Sep; 353(10):1052-4. PubMed ID: 16148291
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Freifeld AG; Sepkowitz KA; Martino P; Steven N; Billingham L; Cullen M; Baden LR
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16394310
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Eller P; Pechlaner C
    N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395828
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
    Cullen M; Steven N; Billingham L; Gaunt C; Hastings M; Simmonds P; Stuart N; Rea D; Bower M; Fernando I; Huddart R; Gollins S; Stanley A;
    N Engl J Med; 2005 Sep; 353(10):988-98. PubMed ID: 16148284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial prophylaxis in neutropenic patients.
    Viscoli C
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S60-5. PubMed ID: 17706926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
    Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone prophylaxis in patients with neutropenia.
    Zinner SH
    Clin Infect Dis; 2005 Apr; 40(8):1094-5. PubMed ID: 15791506
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational selection of patients for antibacterial prophylaxis after chemotherapy.
    Cullen MH; Billingham LJ; Gaunt CH; Steven NM
    J Clin Oncol; 2007 Oct; 25(30):4821-8. PubMed ID: 17947731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
    Lo N; Cullen M
    Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Empirical antimicrobial therapy in a patient with neutropenia].
    Anttila VJ; Ruotsalainen E
    Duodecim; 2002; 118(21):2241-7. PubMed ID: 12486961
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
    Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
    Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice of empirical therapy and prophylaxis.
    Del Favero A; Bucaneve G; Furno P
    Hematol J; 2004; 5 Suppl 3():S53-8. PubMed ID: 15190279
    [No Abstract]   [Full Text] [Related]  

  • 19. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized prospective study of oral levofloxacin vs intravenous flomoxef prophylaxis in postoperative infection after endoscopic sinus surgery.
    Inoshita A; Yokoi H; Matsumoto F; Yao T; Kawano K; Furukawa M; Ikeda K
    Am J Otolaryngol; 2010; 31(5):360-3. PubMed ID: 20015788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.